Chemicals
Compare Stocks
2 / 10Stock Comparison
HUN vs CC
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
HUN vs CC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Chemicals | Chemicals - Specialty |
| Market Cap | $2.63B | $3.55B |
| Revenue (TTM) | $5.69B | $5.82B |
| Net Income (TTM) | $-324M | $-411M |
| Gross Margin | 12.9% | 15.1% |
| Operating Margin | -1.0% | -0.8% |
| Forward P/E | — | 16.4x |
| Total Debt | $2.73B | $4.58B |
| Cash & Equiv. | $429M | $672M |
HUN vs CC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Huntsman Corporation (HUN) | 100 | 83.2 | -16.8% |
| The Chemours Company (CC) | 100 | 180.5 | +80.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HUN vs CC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HUN carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 1.73, yield 5.6%
- Lower volatility, beta 1.73, Low D/E 92.5%, current ratio 1.30x
- Beta 1.73, yield 5.6%, current ratio 1.30x
CC is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 0.4%, EPS growth -5.5%, 3Y rev CAGR -5.3%
- 205.3% 10Y total return vs HUN's 50.8%
- 0.4% revenue growth vs HUN's -5.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 0.4% revenue growth vs HUN's -5.8% | |
| Value | Better valuation composite | |
| Quality / Margins | -5.7% margin vs CC's -7.1% | |
| Stability / Safety | Beta 1.73 vs CC's 1.92, lower leverage | |
| Dividends | 5.6% yield, vs CC's 2.2% | |
| Momentum (1Y) | +98.5% vs HUN's +38.4% | |
| Efficiency (ROA) | -4.6% ROA vs CC's -5.5%, ROIC -0.6% vs -0.1% |
HUN vs CC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HUN vs CC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CC and HUN operate at a comparable scale, with $5.8B and $5.7B in trailing revenue. Profitability is closely matched — net margins range from -5.7% (HUN) to -7.1% (CC).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $5.7B | $5.8B |
| EBITDAEarnings before interest/tax | $160M | -$132M |
| Net IncomeAfter-tax profit | -$324M | -$411M |
| Free Cash FlowCash after capex | $135M | $198M |
| Gross MarginGross profit ÷ Revenue | +12.9% | +15.1% |
| Operating MarginEBIT ÷ Revenue | -1.0% | -0.8% |
| Net MarginNet income ÷ Revenue | -5.7% | -7.1% |
| FCF MarginFCF ÷ Revenue | +2.4% | +3.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.7% | +1.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.3% | -6.1% |
Valuation Metrics
HUN leads this category, winning 5 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, HUN's 19.9x EV/EBITDA is more attractive than CC's 22.3x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $2.6B | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $4.9B | $7.5B |
| Trailing P/EPrice ÷ TTM EPS | -9.50x | -9.25x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 19.89x | 22.29x |
| Price / SalesMarket cap ÷ Revenue | 0.46x | 0.61x |
| Price / BookPrice ÷ Book value/share | 0.88x | 14.20x |
| Price / FCFMarket cap ÷ FCF | 22.65x | 69.66x |
Profitability & Efficiency
HUN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
HUN delivers a -8.1% return on equity — every $100 of shareholder capital generates $-8 in annual profit, vs $-163 for CC. HUN carries lower financial leverage with a 0.92x debt-to-equity ratio, signaling a more conservative balance sheet compared to CC's 18.27x. On the Piotroski fundamental quality scale (0–9), CC scores 4/9 vs HUN's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -8.1% | -163.4% |
| ROA (TTM)Return on assets | -4.6% | -5.5% |
| ROICReturn on invested capital | -0.6% | -0.1% |
| ROCEReturn on capital employed | -0.7% | -0.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 |
| Debt / EquityFinancial leverage | 0.92x | 18.27x |
| Net DebtTotal debt minus cash | $2.3B | $3.9B |
| Cash & Equiv.Liquid assets | $429M | $672M |
| Total DebtShort + long-term debt | $2.7B | $4.6B |
| Interest CoverageEBIT ÷ Interest expense | -1.08x | 0.86x |
Total Returns (Dividends Reinvested)
CC leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CC five years ago would be worth $8,087 today (with dividends reinvested), compared to $6,210 for HUN. Over the past 12 months, CC leads with a +98.5% total return vs HUN's +38.4%. The 3-year compound annual growth rate (CAGR) favors CC at -3.9% vs HUN's -12.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +49.0% | +93.9% |
| 1-Year ReturnPast 12 months | +38.4% | +98.5% |
| 3-Year ReturnCumulative with dividends | -31.9% | -11.4% |
| 5-Year ReturnCumulative with dividends | -37.9% | -19.1% |
| 10-Year ReturnCumulative with dividends | +50.8% | +205.3% |
| CAGR (3Y)Annualised 3-year return | -12.0% | -3.9% |
Risk & Volatility
HUN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HUN is the less volatile stock with a 1.73 beta — it tends to amplify market swings less than CC's 1.92 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HUN currently trades 95.0% from its 52-week high vs CC's 82.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.73x | 1.92x |
| 52-Week HighHighest price in past year | $15.89 | $28.67 |
| 52-Week LowLowest price in past year | $7.30 | $9.13 |
| % of 52W HighCurrent price vs 52-week peak | +95.0% | +82.6% |
| RSI (14)Momentum oscillator 0–100 | 64.6 | 73.9 |
| Avg Volume (50D)Average daily shares traded | 6.2M | 3.1M |
Analyst Outlook
HUN leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates HUN as "Hold" and CC as "Hold". Consensus price targets imply -6.5% upside for CC (target: $22) vs -20.5% for HUN (target: $12). For income investors, HUN offers the higher dividend yield at 5.60% vs CC's 2.19%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $12.00 | $22.14 |
| # AnalystsCovering analysts | 33 | 20 |
| Dividend YieldAnnual dividend ÷ price | +5.6% | +2.2% |
| Dividend StreakConsecutive years of raises | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.85 | $0.52 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% |
HUN leads in 4 of 6 categories (Valuation Metrics, Profitability & Efficiency). CC leads in 2 (Income & Cash Flow, Total Returns).
HUN vs CC: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is HUN or CC a better buy right now?
For growth investors, The Chemours Company (CC) is the stronger pick with 0.
4% revenue growth year-over-year, versus -5. 8% for Huntsman Corporation (HUN). Analysts rate Huntsman Corporation (HUN) a "Hold" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HUN or CC?
Over the past 5 years, The Chemours Company (CC) delivered a total return of -19.
1%, compared to -37. 9% for Huntsman Corporation (HUN). Over 10 years, the gap is even starker: CC returned +205. 3% versus HUN's +50. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HUN or CC?
By beta (market sensitivity over 5 years), Huntsman Corporation (HUN) is the lower-risk stock at 1.
73β versus The Chemours Company's 1. 92β — meaning CC is approximately 11% more volatile than HUN relative to the S&P 500. On balance sheet safety, Huntsman Corporation (HUN) carries a lower debt/equity ratio of 92% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.
04Which is growing faster — HUN or CC?
By revenue growth (latest reported year), The Chemours Company (CC) is pulling ahead at 0.
4% versus -5. 8% for Huntsman Corporation (HUN). On earnings-per-share growth, the picture is similar: Huntsman Corporation grew EPS -44. 5% year-over-year, compared to -549. 1% for The Chemours Company. Over a 3-year CAGR, CC leads at -5. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — HUN or CC?
Huntsman Corporation (HUN) is the more profitable company, earning -4.
8% net margin versus -6. 6% for The Chemours Company — meaning it keeps -4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CC leads at -0. 1% versus -0. 7% for HUN. At the gross margin level — before operating expenses — CC leads at 15. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is HUN or CC more undervalued right now?
Analyst consensus price targets imply the most upside for CC: -6.
5% to $22. 14.
07Which pays a better dividend — HUN or CC?
All stocks in this comparison pay dividends.
Huntsman Corporation (HUN) offers the highest yield at 5. 6%, versus 2. 2% for The Chemours Company (CC).
08Is HUN or CC better for a retirement portfolio?
For long-horizon retirement investors, Huntsman Corporation (HUN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (5.
6% yield). The Chemours Company (CC) carries a higher beta of 1. 92 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HUN: +50. 8%, CC: +205. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between HUN and CC?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HUN is a small-cap income-oriented stock; CC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.